Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failure
1. 请及时下载文件确认是否正确, 系统将在 2026-09-22 14:42:11 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1038/s41409-026-02825-0
文献链接: https://www.nature.com/articles/s41409-026-02825-0
其他信息:
出版社: Springer Science and Business Media LLC
作者: Johannes Clausen; José Antonio Pérez Simón; Martin Carré; Cristina Castilla-Llorente; David Michonneau; Alexander Schauwvlieghe; Pedro Asensi Cantó; Sylvie François; Ludovic Gabellier; Lucía López Corral; Ana Benzaquén; Hélène Labussière-Wallet; Jérome Cornillon; Raynier Devillier; Anne Huynh; Pascal Turlure; Anna Bauhofer; Hervé Jullien de Pommerol; Marion Bruelle; Imi Faghmous; Behzad Kharabi Masouleh; Emilie Plantamura; Florent Malard; Mohamad Mohty
全文下载地址: https://www.nature.com/articles/s41409-026-02825-0.pdf
